PMV Pharmaceuticals, Inc. - PMVP
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | Euclidean Capital LLC | 4.9% | 2,627,643 | View |
| May 15, 2026 | SCHEDULE 13G/A | Marilyn H. Simons | 4.9% | 2,627,643 | View |
| May 15, 2026 | SCHEDULE 13G/A | Ashvin B. Chhabra | 4.9% | 2,627,643 | View |
| May 15, 2026 | SCHEDULE 13G/A | Greenland NFP B Ltd. | 2.4% | 1,300,818 | View |
| May 15, 2026 | SCHEDULE 13G/A | Greenland NFP LLC | 0.1% | 66,300 | View |
| May 15, 2026 | SCHEDULE 13G/A | Greenland A LLC | 0.7% | 346,884 | View |
| May 15, 2026 | SCHEDULE 13G/A | Symmetry Group Ltd. | 0.5% | 247,203 | View |
| May 04, 2026 | SCHEDULE 13G/A | Sio Capital Management, LLC | 5.77% | 3,076,580 | View |
| Mar 04, 2026 | SCHEDULE 13D/A | — | 1.0% | — | View |
| Feb 17, 2026 | SCHEDULE 13G/A | ArrowMark Colorado Holdings, LLC | 5.81% | 3,090,093 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | BML Investment Partners, L.P. | 9.9% | 5,292,000 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.